The EGFR Inhibitor Gefitinib Enhanced the Response of Human Oral Squamous Cell Carcinoma to Cisplatin In Vitro.
about
The EGFR Inhibitor Gefitinib Enhanced the Response of Human Oral Squamous Cell Carcinoma to Cisplatin In Vitro.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The EGFR Inhibitor Gefitinib E ...... rcinoma to Cisplatin In Vitro.
@en
The EGFR Inhibitor Gefitinib E ...... rcinoma to Cisplatin In Vitro.
@nl
type
label
The EGFR Inhibitor Gefitinib E ...... rcinoma to Cisplatin In Vitro.
@en
The EGFR Inhibitor Gefitinib E ...... rcinoma to Cisplatin In Vitro.
@nl
prefLabel
The EGFR Inhibitor Gefitinib E ...... rcinoma to Cisplatin In Vitro.
@en
The EGFR Inhibitor Gefitinib E ...... rcinoma to Cisplatin In Vitro.
@nl
P2860
P1433
P1476
The EGFR Inhibitor Gefitinib E ...... rcinoma to Cisplatin In Vitro.
@en
P2093
Ashraf Khalil
Mark J Jameson
P2860
P304
P356
10.1007/S40268-017-0204-X
P577
2017-08-21T00:00:00Z